121 related articles for article (PubMed ID: 38006758)
1. Impact of colorectal cancer screening on survival after metachronous metastasis.
Hamers PAH; Vink GR; Elferink MAG; Moons LMG; Punt CJA; May AM; Koopman M
Eur J Cancer; 2024 Jan; 196():113429. PubMed ID: 38006758
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
3. Impact of the faecal immunochemical test on colorectal cancer survival.
Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
[TBL] [Abstract][Full Text] [Related]
4. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
[TBL] [Abstract][Full Text] [Related]
5. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
[TBL] [Abstract][Full Text] [Related]
6. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
[TBL] [Abstract][Full Text] [Related]
7. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.
Mekenkamp LJ; Koopman M; Teerenstra S; van Krieken JH; Mol L; Nagtegaal ID; Punt CJ
Br J Cancer; 2010 Jul; 103(2):159-64. PubMed ID: 20551951
[TBL] [Abstract][Full Text] [Related]
9. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
10. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
[TBL] [Abstract][Full Text] [Related]
11. Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
Bakkers C; Lurvink RJ; Rijken A; Nienhuijs SW; Kok NF; Creemers GJ; Verhoef C; Lemmens VE; van Erning FN; De Hingh IH
Ann Surg Oncol; 2021 Dec; 28(13):9073-9083. PubMed ID: 34076807
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
14. Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors.
Ihn MH; Kim DW; Cho S; Oh HK; Jheon S; Kim K; Shin E; Lee HS; Chung JH; Kang SB
Cancer Res Treat; 2017 Jan; 49(1):104-115. PubMed ID: 27188203
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of disease-free interval in colorectal cancer: Is it time?
Birgin E; Doyon F; Burkert J; Téoule P; Rasbach E; Rahbari M; Reissfelder C; Betzler A; Rahbari NN
Eur J Surg Oncol; 2022 Sep; 48(9):2032-2038. PubMed ID: 35738980
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
18. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
19. Biopsy of Non-tumor Sites After Biopsy of a Colorectal Cancer is not Associated With Metachronous Cancers: A Case-control Study.
Lam AY; Lee JK; Merchant S; Jensen CD; Sedki M; Corley DA
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):487-496.e3. PubMed ID: 35644341
[TBL] [Abstract][Full Text] [Related]
20. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]